| Daniel Sivert Miller, MD | |
|
909 E San Marnan Drive, Waterloo, IA 50702-5611 | |
| (319) 234-2616 | |
| (319) 234-1939 |
| Full Name | Daniel Sivert Miller |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 29 Years |
| Location | 909 E San Marnan Drive, Waterloo, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427098466 | NPI | - | NPPES |
| 0234120 | Medicaid | IA | |
| 421417307E9 | Other | IA | JOHN DEERE HEALTH INS |
| 26686 | Other | IA | WELLMARK INS PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 34049 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Waterloo Medical Center | Waterloo, IA | Hospital |
| Buchanan County Health Center | Independence, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cedar Valley Medical Specialists Pc | 1759291487 | 100 |
News Archive
Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.
French researchers have found a way to identify quickly the 5-10% of patients in whom the commonly used painkiller, tramadol, does not work effectively. A simple blood test can produce a result within a few hours, enabling doctors to switch a non-responding patient on to another painkiller, such as morphine, which will be able to work in these patients.
IMRIS Inc. ("IMRIS" or the "Company") today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA), permitting the Company to market its newest products, IMRISNV and IMRIScardio in the United States.
The condition of mice with a genetic blood disease called beta-thalassemia improved significantly following treatment of their blood forming cells with a gene that enabled them to produce the type of hemoglobin normally found only in the fetus.
A new study published on the preprint server medRxiv* in May 2020 shows that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease can remain viable for a maximum of one week on smooth environmental surfaces, for several hours in human feces, and for a maximum of 4 days in human urine. This knowledge could help guide disinfection policies to control the virus spread.
› Verified 8 days ago
| Entity Name | Cedar Valley Medical Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497794242 PECOS PAC ID: 1759291487 Enrollment ID: O20031208000462 |
News Archive
Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.
French researchers have found a way to identify quickly the 5-10% of patients in whom the commonly used painkiller, tramadol, does not work effectively. A simple blood test can produce a result within a few hours, enabling doctors to switch a non-responding patient on to another painkiller, such as morphine, which will be able to work in these patients.
IMRIS Inc. ("IMRIS" or the "Company") today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA), permitting the Company to market its newest products, IMRISNV and IMRIScardio in the United States.
The condition of mice with a genetic blood disease called beta-thalassemia improved significantly following treatment of their blood forming cells with a gene that enabled them to produce the type of hemoglobin normally found only in the fetus.
A new study published on the preprint server medRxiv* in May 2020 shows that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease can remain viable for a maximum of one week on smooth environmental surfaces, for several hours in human feces, and for a maximum of 4 days in human urine. This knowledge could help guide disinfection policies to control the virus spread.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Sivert Miller, MD Po Box 2758, Waterloo, IA 50704-2758 Ph: (319) 234-2616 | Daniel Sivert Miller, MD 909 E San Marnan Drive, Waterloo, IA 50702-5611 Ph: (319) 234-2616 |
News Archive
Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.
French researchers have found a way to identify quickly the 5-10% of patients in whom the commonly used painkiller, tramadol, does not work effectively. A simple blood test can produce a result within a few hours, enabling doctors to switch a non-responding patient on to another painkiller, such as morphine, which will be able to work in these patients.
IMRIS Inc. ("IMRIS" or the "Company") today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA), permitting the Company to market its newest products, IMRISNV and IMRIScardio in the United States.
The condition of mice with a genetic blood disease called beta-thalassemia improved significantly following treatment of their blood forming cells with a gene that enabled them to produce the type of hemoglobin normally found only in the fetus.
A new study published on the preprint server medRxiv* in May 2020 shows that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease can remain viable for a maximum of one week on smooth environmental surfaces, for several hours in human feces, and for a maximum of 4 days in human urine. This knowledge could help guide disinfection policies to control the virus spread.
› Verified 8 days ago
Dr. Richard C Mauer, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2515 Cyclone Dr, Waterloo, IA 50701 Phone: 319-433-3000 Fax: 319-232-1155 | |
Benjamin L Mason, M.D.. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 999 Home Plz, Waterloo, IA 50701 Phone: 319-287-5890 Fax: 319-287-5079 | |
Dr. Thomas Paul Petrie, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 909 E San Marnan Dr, Waterloo, IA 50702 Phone: 319-233-2020 | |
Peter Rhee, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 999 Home Plaza, Suite 101 Wolfe Eye Clinic, Waterloo, IA 50701 Phone: 319-287-5890 Fax: 319-287-5079 | |
Michael John Puk, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 909 E San Marnan Drive, Waterloo, IA 50702 Phone: 319-234-2616 Fax: 319-234-1939 |